Cerebral venous sinus thrombosis risk across various oral contraceptives: a disproportionality analysis of the FDA adverse event reporting system
Crossref DOI link: https://doi.org/10.1007/s00415-026-13846-6
Published Online: 2026-05-15
Published Print: 2026-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Balshi, Alexandra https://orcid.org/0000-0002-3202-6921
Text and Data Mining valid from 2026-05-15
Version of Record valid from 2026-05-15
Article History
Received: 25 March 2026
Revised: 25 April 2026
Accepted: 27 April 2026
First Online: 15 May 2026
Declarations
:
: None.